Anni Mörö is Founder and COO of StemSight. StemSight is a pre-clinical stage biopharma company developing proprietary hypoimmunogenic, allogeneic cell-based therapies derived from human induced pluripotent stem cells (iPSCs) to treat corneal diseases. Anni has 15 years of experience developing ocular cell therapies from human pluripotent stem cells. Throughout her academic career, she has been involved in projects where commercialization of research-based innovations are explored. This has led to founding of two science-packed spin-off companies in the advanced therapeutics area. Her contributions to medical innovation have been recognized with the Pirkanmaa Award.  Anni is passionate about technology and innovation management. She actively supports and mentors other female founders.